Elevance Health, Inc. (LON:0HG8)
380.00
+6.31 (1.69%)
At close: Jun 27, 2025
Elevance Health Revenue
Elevance Health had revenue of $48.89B USD in the quarter ending March 31, 2025, with 14.83% growth. This brings the company's revenue in the last twelve months to $183.12B, up 6.63% year-over-year. In the year 2024, Elevance Health had annual revenue of $176.81B with 3.19% growth.
Revenue (ttm)
$183.12B
Revenue Growth
+6.63%
P/S Ratio
0.44
Revenue / Employee
$1.76M
Employees
104,200
Market Cap
62.85B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 176.81B | 5.47B | 3.19% |
Dec 31, 2023 | 171.34B | 14.74B | 9.41% |
Dec 31, 2022 | 156.60B | 17.96B | 12.95% |
Dec 31, 2021 | 138.64B | 16.78B | 13.76% |
Dec 31, 2020 | 121.87B | 17.66B | 16.94% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 42.56B |
GSK plc | 31.53B |
Haleon | 11.23B |
Smith & Nephew | 4.64B |
ConvaTec Group | 1.83B |
Hikma Pharmaceuticals | 2.50B |
HUTCHMED (China) | 503.39M |
Genus | 671.60M |
Elevance Health News
- 4 days ago - DEADLINE APPROACHING: Berger Montague Advises Elevance Health (NYSE: ELV) Investors to Inquire About a Securities Fraud Class Action by July 11, 2025 - PRNewsWire
- 4 days ago - ROSEN, LEADING INVESTOR COUNSEL, Encourages Elevance Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ELV - GlobeNewsWire
- 4 days ago - Elevance Health, Inc. (ELV) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PRNewsWire
- 4 days ago - Elevance Health Foundation Invests $1.5 Million to Accelerate Doula Training with HealthConnect One - Business Wire
- 5 days ago - ELV INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Elevance Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - GlobeNewsWire
- 5 days ago - Deadline Alert: Elevance Health, Inc. (ELV) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit - GlobeNewsWire
- 5 days ago - INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Elevance Health - GlobeNewsWire
- 5 days ago - ELV Investors Have Opportunity to Lead Elevance Health, Inc. Securities Fraud Lawsuit with the Schall Law Firm - PRNewsWire